Related to FDA Approves Tysabri Label Change and Test for JC Virus Infection in MS Patients

• Spinreact to Include AbD Serotec Antibodies in Clinical Diagnostic Kits
  
• FDA Gives Osmetech’s Cystic Fibrosis Genotyping Test a Thumbs Up
  
• GW Pharmaceuticals’ Plant for MS and Cancer Pain Drug Gets U.K. GMP Clearance
  
• FDA Says Erbitux No Good for Those with Certain K-ras Mutations
  
• FDA Clears Novartis Medication as Initial Therapy for Blood Pressure
  
• Axial Biotech Selects University of Utah Database to Develop Personalized Tests for Spine Disorders
  
• Cryopraxis to Assess Cryo-Cell's Menstrual Stem Cell Technology for Diagnosing Endometriosis
  
• BioMS Stock Free-Falls as Late-Stage Development of Sole Clinical Candidate Gets the Axe
  
• QuantRx Creates Joint Venture with NuRx Focused on Point-of-Care Products
  
• FDA Gives Roche’s Avastin the Go-Ahead for Metastatic Renal Carcinoma
  
• MP Biomedicals to Develop Alzheimer’s Blood Test Based on UCLA Technology
  
• Rosetta Genomics Taps Warnex as Canadian Distributor for Cancer Diagnostics
  
• FDA Clears Sandoz’ Generic Competitor to Astellas Transplant Drug
  
• Arup Taps Epigenomics’ mSEPT9 Biomarker to Develop Colorectal Cancer Test
  
• Geron’s hESC Therapy for Spinal Cord Injury Has Been Placed on Hold
  
• FDA Raps J&J's Knuckles over Clinical Trials of Ceftobiprole Antibiotic
  
• GSK Wins Accelerated Approval of Hib Vaccine to Help Sustain Supply
  
• MediciNova and Avigen Agree to Merge
  
• Clinical Reference Sets Up U.K. Lab along with Quotient Bioresearch
  
• Warnex Develops Test to Detect Swine Flu Virus Mutation Linked to Tamiflu Resistance